Apr 12, 2023 · In 2017, FDA announced the Drug Competition Action Plan (DCAP) to further encourage robust and timely market competition for generic drugs and help bring greater efficiency and transparency to the Nexium 24HR is one of the biggest-selling over-the-counter treatments for frequent heartburn, with annual sales estimated at more than $300 million
In addition to Lipitor and Epogen
A 2017 study found esomeprazole to be among a number of effective PPIs
An early generic launch against Nexium could hit AstraZeneca’s earnings per share by 11% annually, the firm projected, and Merck’s EPS by around 5%
Mar 23, 2021
DUBLIN, Aug
What is Nexium? Nexium is a proton pump inhibitor that decreases the amount of acid produced in the stomach
Nexium effectively heals inflamed tissue in the gastrointestinal tract and relieves symptoms of heartburn